18F‐Fluorodeoxyglucose–Positron Emission Tomography As an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients With Large Vessel Vasculitis

Arthritis and Rheumatology - Tập 70 Số 3 - Trang 439-449 - 2018
Peter C. Grayson1, Sara Alehashemi1, Armin A. Bagheri1, A. Cahid Civelek2, Thomas R. Cupps3, Mariana J. Kaplan1, Ashkan A. Malayeri2, Peter A. Merkel4, Elaine Novakovich1, David A. Bluemke2, Mark A. Ahlman2
1National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH Bethesda Maryland
2Radiology and Imaging Sciences NIH Bethesda Maryland
3Georgetown University, Washington, DC
4University of Pennsylvania, Philadelphia

Tóm tắt

ObjectiveTo assess the clinical value of18F‐fluorodeoxyglucose (FDG) positron emission tomography (PET) in a prospective cohort of patients with large vessel vasculitis (LVV) and comparator subjects.MethodsPatients with Takayasu arteritis and giant cell arteritis were studied, along with a comparator group consisting of patients with hyperlipidemia, patients with diseases that mimicLVV, and healthy controls. Participants underwent clinical evaluation andFDGPETimaging, and patients withLVVunderwent serial imaging at 6‐month intervals. We calculated sensitivity and specificity ofFDGPETinterpretation for distinguishing patients with clinically activeLVVfrom comparator subjects and from patients with disease in clinical remission. A qualitative summary score based on global arterialFDGuptake, thePETVascular Activity Score (PETVAS), was used to study associations between activity onPETscan and clinical characteristics and to predict relapse.ResultsA total of 170FDGPETscans were performed in 115 participants (56 patients withLVVand 59 comparator subjects).FDGPETdistinguished patients with clinically activeLVVfrom comparator subjects with a sensitivity of 85% (95% confidence interval [95%CI] 69, 94) and a specificity of 83% (95%CI71, 91).FDGPETscans were interpreted as active vasculitis in most patients withLVVin clinical remission (41 of 71 [58%]). Clinical disease activity status, disease duration, body mass index, and glucocorticoid use were independently associated with activity onPETscan. Among patients who underwentPETduring clinical remission, future clinical relapse was more common in patients with a highPETVASthan in those with a lowPETVAS(55% versus 11%;P = 0.03) over a median follow‐up period of 15 months.ConclusionFDGPETprovides information about vascular inflammation that is complementary to, and distinct from, clinical assessment inLVV.FDGPETscan activity during clinical remission was associated with future clinical relapse.

Từ khóa


Tài liệu tham khảo

10.1056/NEJMra050276

10.1007/s11883-012-0264-x

10.1186/s13075-014-0423-2

10.1002/art.37715

10.3899/jrheum.110275

10.7326/0003-4819-120-11-199406010-00004

10.1038/modpathol.2017.10

10.1136/ard.2008.088351

10.1111/1756-185X.12713

10.1007/s00259-013-2545-1

10.1259/bjr/16422950

10.1007/s00259-004-1757-9

Henes JC, 2008, [18F] FDG‐PET/CT as a new and sensitive imaging method for the diagnosis of large vessel vasculitis, Clin Exp Rheumatol, 26, S47

10.1007/s10067-010-1598-9

10.1136/annrheumdis-2013-204572

10.2967/jnumed.108.051920

10.1007/s00259-011-1967-x

10.1002/art.1780330811

10.1002/art.1780330810

10.1136/annrheumdis-2011-200795

Sandfort V, 2016, Obesity is associated with progression of atherosclerosis during statin treatment, J Am Heart Assoc, 5, e003621, 10.1161/JAHA.116.003621

10.1007/s00259-003-1144-y

10.1002/art.39517

10.1016/j.jacc.2011.03.044

10.2967/jnumed.108.060749

Ostberg G, 1972, Morphological changes in the large arteries in polymyalgia arteritica, Acta Med Scand Suppl, 533, 135, 10.1111/j.0954-6820.1972.tb15615.x

10.1002/acr.21750

10.1007/s00393-015-1674-2

10.1007/s00259-015-3259-3

10.1002/art.21699

Kobayashi Y, 2005, Aortic wall inflammation due to Takayasu arteritis imaged with 18F‐FDG PET coregistered with enhanced CT, J Nucl Med, 46, 917

10.1007/s00259-003-1429-1

10.1097/RLU.0b013e3181b7db09

10.1002/art.24416

10.1002/art.33413

10.1016/j.jcmg.2012.01.013

Karapolat I, 2013, Comparison of F18‐FDG PET/CT findings with current clinical disease status in patients with Takayasu's arteritis, Clin Exp Rheumatol, 31, S15

10.1097/MD.0000000000000622

10.1016/j.atherosclerosis.2010.01.002

10.1007/s00259-015-3148-9